The hardest part of essential tremor is rarely the shaking itself; it is the timing. A patient whose medication settles the tremor at breakfast can be unable to sign a form at four in the afternoon, and no adjustment made at the next clinic visit changes the afternoon they already had. On-demand tremor therapy devices exist for that gap: they are worn, activated when the tremor interferes with a specific task, and used for a defined session rather than around the clock.
Last updated:
What an on-demand tremor device is
An on-demand tremor therapy device is a wearable, non-invasive tool that reduces hand tremor by delivering targeted stimulation when it is switched on. It is used for the hand tremor of essential tremor and Parkinson’s disease, and its defining feature is that the patient controls when treatment happens rather than taking it on a fixed schedule.
The practical consequence is that the device competes with medication for task-specific control, not for round-the-clock symptom relief. That is where it fits, and where it does not.
How a wrist-worn device interrupts a tremor
The devices the original article describes, including the Cala kIQ wristband, work through motion sensors that read the tremor and then deliver calibrated stimulation — electrical or mechanical — to disrupt the abnormal signalling producing it. Sessions commonly run about an hour, and an accompanying app logs usage and progress.
Bluetooth links to a clinician allow the protocol to be adjusted remotely against the patient’s own tremor data, which is the part that makes these devices different from an earlier generation of passive splints. Intensity is adjustable, and that adjustment is what a clinician tunes.
On-demand devices against the alternatives
The comparison below keeps the structure the original article used and drops the unsupported percentages; where a cost or duration is genuinely a range rather than a measured figure, it is labelled as one.
| Feature | Medication and therapy | On-demand device |
|---|---|---|
| Activation time | Hours to reach effect; therapy takes weeks | Under a minute |
| Duration of effect | Hours, and variable between patients | About an hour per session, repeatable |
| Cost profile | Recurring annual cost | One-off purchase plus consumables |
| Invasiveness | Systemic (medication) or surgical (DBS) | Non-invasive, worn on the wrist |
| Access | Depends on clinic visits | Used at home, when needed |
| Side effects | Systemic effects reported by some patients | Local skin irritation at the contact points |
The row that decides most real-world choices is the first. A drug that takes an hour to work cannot help a patient who needs a steady hand now, and a device that works in seconds cannot replace continuous control.
Who it suits, and who should ask a physician first
Ideal candidates have mild to moderate tremor and want non-invasive, task-based control — either instead of medication or alongside it. A neurologist should assess the tremor type, severity and treatment goals first, because essential tremor and Parkinsonian tremor respond differently and the device is not a substitute for diagnosis.
Patients with implanted electronic devices, such as a pacemaker or a deep brain stimulator, or with specific neurological conditions should consult a physician before use. Skin irritation at the contact points is the effect most commonly reported, and it is managed rather than a reason to stop treatment unilaterally.
Where the evidence has to come from
Tremor devices are marketed directly to patients, which makes verification harder than it should be. The FDA classifies every device by risk and publishes the premarket record, so a listing that claims clearance should be checkable in the premarket databases, and the model should resolve through the UDI system. Where a device is described as “FDA-cleared” without a submission reference, treat that as a request to be answered rather than a fact to be accepted. Two related notes on this site cover FDA clearance status for tremor devices and medical-grade tremor devices in neurological rehabilitation.
The same caution applies to the prices quoted for these devices: they are sold at consumer prices through clinical channels, and the right comparison is the delivered price with consumables and support rather than the headline figure.
What to compare before buying
Compare adjustable stimulation levels, weight and wearability over an hour, battery life against daily use, whether the app supports clinician review, and the warranty and consumable terms. A device that is comfortable for ten minutes and unusable for sixty will not be worn, and adherence is the whole therapy.
Where the device is prescribed, confirm how the protocol is set and reviewed, because remote adjustment is the feature that distinguishes an on-demand device from an assistive gadget.

References
- FDA: Medical Device Databases — Devices@FDA premarket notifications and approvals, and quarterly registration and listing.
- FDA: Classify Your Medical Device — risk class and the premarket route.
- FDA: Unique Device Identification System (UDI System) — how to resolve a model on its label.
- FDA: Medical Device Recalls and Early Alerts.
Check the clearance before the claim. A listing that names a model should let you resolve its premarket record.
FAQ
Does an on-demand tremor device replace medication?
Usually not. Medication provides systemic control across the day, while an on-demand device provides task-specific relief for about an hour at a time. Many patients combine both, and the decision belongs with the treating neurologist rather than with the device listing.
How do I verify that a tremor device is actually cleared?
Ask for the submission reference and match the model against the FDA premarket databases, then resolve the model through the UDI system. A clearance claim without a reference is a request for information rather than evidence.
Who should not use one without medical advice?
Patients with implanted electronic devices such as pacemakers or deep brain stimulators, and those with specific neurological conditions, should consult a physician first. Skin irritation at the contact points is the effect most commonly reported.
Why is the session limited to about an hour?
Because the effect is task-scoped rather than continuous. The device is used when a steady hand is needed, and it is repeatable through the day, which is a different model from a drug taken on a fixed schedule.
What matters most when comparing two devices?
Comfort over a full session, adjustable intensity, battery life against real daily use, whether a clinician can review the data remotely, and the warranty and consumable terms. Adherence decides the outcome, and adherence follows comfort.
Part of the Tremor & Neuromodulation Therapy guide.
Related articles
Remote Monitoring of Medical Equipment: What You Can and Cannot SeeKnowledge
HL7 and Device Integration When Buying Used Equipment: Compatibility Before PriceKnowledge
Transferring Medical Software Licences: What Moves With the HardwareKnowledge
Isolating Legacy Medical Devices on a Network: Compensating Controls That Hold UpKnowledge